Literature DB >> 1748136

Comparison of the cardiovascular effects of nifedipine and nicardipine in the presence of atenolol.

S H Thomas1.   

Abstract

A placebo controlled double blind crossover study was performed in 12 healthy volunteers to compare the cardiovascular effects of single oral doses of nifedipine (5, 10 and 15 mg) and nicardipine (20 and 30 mg) in the presence of atenolol 100 mg. Haemodynamic measurements were made by transthoracic electrical bioimpedance cardiography (TEBC) 2 h following drug administration during passive tilting, graded bicycle exercise (30-150 W) and recovery from exercise. In the absence of calcium channel blockade, atenolol reduced mean blood pressure, heart rate, and cardiac index, and increased stroke volume, peripheral resistance, pre-ejection period, and ventricular ejection time, particularly during and after exercise. In comparison with atenolol alone, addition of nifedipine or nicardipine reduced peripheral resistance but did not produce significant changes in stroke volume, cardiac output, dZ/dt [max], pre-ejection period (PEP). Ventricular ejection time (VET), PEP/VET, or Heather index at any point in the experiment. Similar reductions in peripheral resistance were produced by nifedipine 10 mg and nicardipine 20 and 30 mg. These apparently equivalent doses of nifedipine and nicardipine had similar effects on stroke volume, cardiac index, PEP/VET and Heather index. Thus the increases in ventricular performance previously demonstrated in association with nifedipine and nicardipine therapy were not observed in the presence of beta-adrenoceptor blockade. Under these conditions no important differences have been observed in the cardiovascular effects of these two calcium channel blockers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748136     DOI: 10.1007/BF00315430

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  33 in total

1.  Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function.

Authors:  I N Findlay; K MacLeod; M Ford; G Gillen; A T Elliott; H J Dargie
Journal:  Br Heart J       Date:  1986-03

2.  Use of invasive ergometric exercise to assess the hemodynamic response to nicardipine.

Authors:  R J Cody
Journal:  Am J Cardiol       Date:  1987-06-30       Impact factor: 2.778

3.  Adverse interaction between nifedipine and beta-blockade.

Authors:  J S Staffurth; P Emery
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-17

4.  Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function.

Authors:  P A Ludbrook; A J Tiefenbrunn; F R Reed; B E Sobel
Journal:  Circulation       Date:  1982-03       Impact factor: 29.690

5.  Comparative measurements of left ventricular ejection time by mechano-, echo- and electrical impedance cardiography.

Authors:  H C Stern; G K Wolf; G G Belz
Journal:  Arzneimittelforschung       Date:  1985

6.  Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris.

Authors:  M B Leon; D R Rosing; R O Bonow; L C Lipson; S E Epstein
Journal:  Am J Cardiol       Date:  1981-07       Impact factor: 2.778

7.  Long-term therapy of arterial hypertension with nifedipine given alone or in combination with a beta-adrenoceptor blocking agent.

Authors:  S E Husted; H K Nielsen; C K Christensen; O Lederballe Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Impaired early left ventricular relaxation in coronary artery disease: effects of intracornary nifedipine.

Authors:  M F Rousseau; C Veriter; J M Detry; L Brasseur; H Pouleur
Journal:  Circulation       Date:  1980-10       Impact factor: 29.690

9.  Intrinsic and reflex actions of verapamil and nifedipine: assessment in normal subjects by noninvasive techniques and autonomic blockade.

Authors:  H C Stern; J H Matthews; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Atenolol-nifedipine combinations compared to atenolol alone in hypertension: efficacy and tolerability.

Authors:  D Maclean; E T Mitchell; R R Coulson; T J Fitzsimons; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

View more
  1 in total

1.  Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography.

Authors:  S H Thomas; R C Cooper; M Ekwuru; S Fletcher; J Gilbody; T S Husseyin; M Ishaque; R Jagathesan; G Reddy; S E Smith
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.